Summary & Overview
HCPCS C9800: Dermal Injection for Facial Lipodystrophy with Radiesse or Sculptra
HCPCS Level II code C9800 denotes a bundled dermal injection procedure for facial lipodystrophy syndrome (LDS) that includes provision of Radiesse or Sculptra dermal fillers and all associated items and supplies. The code captures a procedural service that addresses facial soft-tissue volume loss, a clinically significant issue affecting appearance and related functional concerns for patients with lipodystrophy. Nationally, such codes inform coverage determinations, billing consistency, and utilization monitoring for aesthetic and reconstructive injectable therapies.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what the code represents, typical sites of service, and the clinical context for use. The publication outlines expected benchmarks for coding practice, summarizes payer coverage considerations, and highlights policy implications for bundled procedural codes tied to specific branded fillers. Where input data is not available, the text notes that gaps exist and refrains from speculation.
This summary serves clinicians, billing professionals, and policy analysts seeking a national-level understanding of HCPCS Level II code C9800, its clinical purpose, and the payer landscape surrounding dermal filler procedures for facial lipodystrophy.
Billing Code Overview
HCPCS Level II code C9800 describes a dermal injection procedure for facial lipodystrophy syndrome (LDS) and includes provision of Radiesse or Sculptra dermal filler, along with all necessary items and supplies. This code represents a bundled procedural service for injectable volumizing treatment targeted at restoring facial soft-tissue volume loss associated with lipodystrophy.
Service Type: Dermal injection procedure with dermal filler provision
Typical Site of Service: Outpatient ambulatory clinic or office-based dermatology/plastic surgery practice
Data not available in the input for modifiers, associated taxonomies, ICD-10 diagnoses, related codes, and service line.
Clinical & Coding Specifications
Clinical Context
A 58-year-old woman with long-standing facial lipoatrophy related to aging and previous HIV-associated lipodystrophy presents to a dermatology or cosmetic surgery clinic requesting volumetric facial restoration. After history, review of medications, and informed consent, the clinician performs a targeted dermal injection session using a calcium hydroxylapatite filler (e.g., Radiesse) or poly-L-lactic acid (e.g., Sculptra) to restore midface and malar fullness. The workflow includes pre-procedure photography, marking of injection sites, application of topical or local anesthesia, sterile preparation of the treatment field, serial injections with appropriate technique (subdermal or deep dermal planes depending on product), immediate post-injection molding as indicated, and patient observation for 15–30 minutes for potential immediate adverse reactions. Documentation includes the billing code C9800, product used (Radiesse or Sculptra), volume per syringe, lot numbers, anesthesia modality, informed consent, site photographs, and post-procedure aftercare instructions. Typical follow-up occurs within 2–4 weeks to assess volumetric response and potential need for additional injections or touch-up sessions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the day of a procedure | Use when a distinct E/M visit is performed the same day as for issues beyond routine pre-procedure assessment |